Keith Katkin, President and CEO at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 218,025 shares at $2.59 ($565K) on 2011-11-17, disclosed to the SEC on 2011-11-18.
Scheduled sale ($565k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.59 | 109,013 | $282K | 50.0% |
| 2 | $2.59 | 109,012 | $282K | 50.0% |
| Total | $2.59 avg | 218,025 | $565K | 100% |
| Filing → |
| SNDX | BUY | 2025-05-19 | $91K | — | Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |